The H22 cell line, also known as Hepatoma-22, is a widely used model in cancer research, particularly in the field of hepatocellular carcinoma (HCC). This mouse-derived cell line offers valuable insights into the effects of novel anti-cancer therapeutic regimens.
At CrownBioscience, we offer the H22 model with unique capabilities. A firefly luciferase-tagged reporter line of the H22 model is available, facilitating disease monitoring via bioluminescent imaging. This allows for precise tracking and monitoring, enhancing the quality of research output.
The H22 cell line, derived from mouse hepatocellular carcinoma (HCC), is primarily used in cancer research, specifically liver cancer studies. The model enables researchers to evaluate the efficacy and pharmacodynamics changes following novel anti-cancer therapeutic regimens. It’s particularly useful in studying the effects of treatments, developing new therapeutic strategies, and understanding the biological and molecular mechanisms of liver cancer progression. Additionally, at CrownBioscience, the H22 model, available as both subcutaneous and orthotopic models, is leveraged for disease monitoring via bioluminescent imaging, offering a valuable tool in tracking tumor growth and response to treatments.
Summary | |
---|---|
Cancer Type | Liver Cancer |
Subtype | N/A |
Mouse Strain | BALB/c |
TMA | TMA-CP-SY-008 |